Parkman Healthcare Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-119,417
| Closed | -$3.46M | – | 113 |
|
|
2023
Q4 | $3.46M | Sell |
119,417
-18,755
| -14% | -$543K | 0.49% | 62 |
|
|
2023
Q3 | $3.81M | Sell |
138,172
-52,007
| -27% | -$1.43M | 0.7% | 40 |
|
|
2023
Q2 | $5.72M | Buy |
190,179
+58,301
| +44% | +$1.75M | 0.99% | 31 |
|
|
2023
Q1 | $4.78M | Buy |
131,878
+36,972
| +39% | +$1.34M | 1.04% | 38 |
|
|
2022
Q4 | $3.39M | Buy |
94,906
+5,197
| +6% | +$185K | 0.9% | 43 |
|
|
2022
Q3 | $3.04M | Buy |
89,709
+1,051
| +1% | +$35.6K | 0.86% | 44 |
|
|
2022
Q2 | $2.56M | Sell |
88,658
-20,296
| -19% | -$587K | 0.94% | 38 |
|
|
2022
Q1 | $3.52M | Buy |
108,954
+4,240
| +4% | +$137K | 1.03% | 36 |
|
|
2021
Q4 | $3.05M | Buy |
104,714
+4,299
| +4% | +$125K | 0.67% | 40 |
|
|
2021
Q3 | $2.68M | Hold |
100,415
| – | – | 0.68% | 46 |
|
|
2021
Q2 | $3.09M | Buy |
+100,415
| New | +$3.09M | 0.68% | 46 |
|